GENTA, SOFIA
GENTA, SOFIA
ONCOLOGIA
A predictive score for optimal cytoreduction at interval debulking surgery in epithelial ovarian cancer: a two- centers experience
2018-01-01 Ghisoni, Eleonora; Katsaros, Dionyssios; Maggiorotto, Furio; Aglietta, Massimo; Vaira, Marco; De Simone, Michele; Mittica, Gloria; Giannone, Gaia; Robella, Manuela; Genta, Sofia; Lucchino, Fabiola; Marocco, Francesco; Borella, Fulvio; Valabrega, Giorgio; Ponzone, Riccardo
Adoptive immunotherapy against ovarian cancer
2016-01-01 Mittica, Gloria; Capellero, Sonia; Genta, Sofia; Cagnazzo, Celeste; Aglietta, Massimo; Sangiolo, Dario; Valabrega, Giorgio
Androgen receptor status predicts development of brain metastases in ovarian cancers
2017-01-01 Mittica, Gloria; Senetta, Rebecca; Scotto, Giulia; Aglietta, Massimo; Maggiorotto, Furio; Ghisoni, Eleonora; Genta, Sofia; Boldorini, Renzo; Manini, Claudia; Morra, Isabella; Buosi, Roberta; Sapino, Anna; Cassoni, Paola; Valabrega, Giorgio
Are cyclin-dependent kinases 4/6 inhibitors ready for prime time in estrogen-receptor positive metastatic breast cancer?
2017-01-01 Genta, Sofia; Mittica, Gloria; Giannone, Gaia; Ghisoni, Eleonora; Valabrega, Giorgio
Checkpoint inhibitors in endometrial cancer: Preclinical rationale and clinical activity
2017-01-01 Mittica, Gloria; Ghisoni, Eleonora; Giannone, Gaia; Aglietta, Massimo; Genta, Sofia; Valabrega, Giorgio
Endometrial Cancer Stem Cells: Role, Characterization and Therapeutic Implications
2019-01-01 Giannone, Gaia; Attademo, Laura; Scotto, Giulia; Genta, Sofia; Ghisoni, Eleonora; Tuninetti, Valentina; Aglietta, Massimo; Pignata, Sandro; Valabrega, Giorgio
Immune checkpoint inhibitors: A new opportunity in the treatment of ovarian cancer?
2016-01-01 Mittica, Gloria; Genta, Sofia; Aglietta, Massimo; Valabrega, Giorgio
Immuno-Metabolism and Microenvironment in Cancer: Key Players for Immunotherapy
2020-01-01 Giannone G.; Ghisoni E.; Genta S.; Scotto G.; Tuninetti V.; Turinetto M.; Valabrega G.
New and developing chemical pharmacotherapy for treating hormone receptor-positive/HER2-negative breast cancer
2016-01-01 Martinello, Rossella; Genta, Sofia; Galizia, Danilo; Geuna, Elena; Milani, Andrea; Zucchini, Giorgia; Valabrega, Giorgio; Montemurro, Filippo
Oral etoposide in heavily pre-treated metastatic breast cancer: A retrospective series
2018-01-01 Giannone, G.; Milani, A.; Ghisoni, E.; Genta, S.; Mittica, G.; Montemurro, F.*; Valabrega, G.
Reprogramming T-cells for adoptive immunotherapy of ovarian cancer
2018-01-01 Genta, Sofia; Ghisoni, Eleonora; Giannone, Gaia; Mittica, Gloria; Valabrega, Giorgio
Secondary cytoreductive surgery, hyperthermic intraperitoneal intraoperative chemotherapy, and chemotherapy alone: A retrospective comparison of alternative approaches in relapsed platinum sensitive ovarian cancer
2016-01-01 Marocco, F.; Vaira, M.; Milani, A.; Genta, S.; Maggiorotto, F.; Magistris, A.; Cinquegrana, A.; Robella, M.; De Simone, M.; Aglietta, M.; Ponzone, R.; Valabrega, G
TOP2A as marker of response to pegylated lyposomal doxorubicin (PLD) in epithelial ovarian cancers
2019-01-01 Ghisoni, Eleonora; Maggiorotto, Furio; Borella, Fulvio; Mittica, Gloria; Genta, Sofia; Giannone, Gaia; Katsaros, Dionyssios; Sciarrillo, Alberto; Ferrero, Annamaria; Sarotto, Ivana; Erriquez, Jessica; Di Renzo, Maria Flavia; Aglietta, Massimo; Valabrega, Giorgio
Veliparib: a new therapeutic option in ovarian cancer?
2019-01-01 Ghisoni, Eleonora; Giannone, Gaia; Tuninetti, Valentina; Genta, Sofia; Scotto, Giulia; Aglietta, Massimo; Sangiolo, Dario; Mittica, Gloria; Valabrega, Giorgio
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A predictive score for optimal cytoreduction at interval debulking surgery in epithelial ovarian cancer: a two- centers experience | 2018 | Ghisoni, Eleonora; Katsaros, Dionyssios; Maggiorotto, Furio; Aglietta, Massimo; Vaira, Marco; De Simone, Michele; Mittica, Gloria; Giannone, Gaia; Robella, Manuela; Genta, Sofia; Lucchino, Fabiola; Marocco, Francesco; Borella, Fulvio; Valabrega, Giorgio; Ponzone, Riccardo | |
| Adoptive immunotherapy against ovarian cancer | 2016 | Mittica, Gloria; Capellero, Sonia; Genta, Sofia; Cagnazzo, Celeste; Aglietta, Massimo; Sangiolo, Dario; Valabrega, Giorgio | |
| Androgen receptor status predicts development of brain metastases in ovarian cancers | 2017 | Mittica, Gloria; Senetta, Rebecca; Scotto, Giulia; Aglietta, Massimo; Maggiorotto, Furio; Ghisoni, Eleonora; Genta, Sofia; Boldorini, Renzo; Manini, Claudia; Morra, Isabella; Buosi, Roberta; Sapino, Anna; Cassoni, Paola; Valabrega, Giorgio | |
| Are cyclin-dependent kinases 4/6 inhibitors ready for prime time in estrogen-receptor positive metastatic breast cancer? | 2017 | Genta, Sofia; Mittica, Gloria; Giannone, Gaia; Ghisoni, Eleonora; Valabrega, Giorgio | |
| Checkpoint inhibitors in endometrial cancer: Preclinical rationale and clinical activity | 2017 | Mittica, Gloria; Ghisoni, Eleonora; Giannone, Gaia; Aglietta, Massimo; Genta, Sofia; Valabrega, Giorgio | |
| Endometrial Cancer Stem Cells: Role, Characterization and Therapeutic Implications | 2019 | Giannone, Gaia; Attademo, Laura; Scotto, Giulia; Genta, Sofia; Ghisoni, Eleonora; Tuninetti, Valentina; Aglietta, Massimo; Pignata, Sandro; Valabrega, Giorgio | |
| Immune checkpoint inhibitors: A new opportunity in the treatment of ovarian cancer? | 2016 | Mittica, Gloria; Genta, Sofia; Aglietta, Massimo; Valabrega, Giorgio | |
| Immuno-Metabolism and Microenvironment in Cancer: Key Players for Immunotherapy | 2020 | Giannone G.; Ghisoni E.; Genta S.; Scotto G.; Tuninetti V.; Turinetto M.; Valabrega G. | |
| New and developing chemical pharmacotherapy for treating hormone receptor-positive/HER2-negative breast cancer | 2016 | Martinello, Rossella; Genta, Sofia; Galizia, Danilo; Geuna, Elena; Milani, Andrea; Zucchini, Giorgia; Valabrega, Giorgio; Montemurro, Filippo | |
| Oral etoposide in heavily pre-treated metastatic breast cancer: A retrospective series | 2018 | Giannone, G.; Milani, A.; Ghisoni, E.; Genta, S.; Mittica, G.; Montemurro, F.*; Valabrega, G. | |
| Reprogramming T-cells for adoptive immunotherapy of ovarian cancer | 2018 | Genta, Sofia; Ghisoni, Eleonora; Giannone, Gaia; Mittica, Gloria; Valabrega, Giorgio | |
| Secondary cytoreductive surgery, hyperthermic intraperitoneal intraoperative chemotherapy, and chemotherapy alone: A retrospective comparison of alternative approaches in relapsed platinum sensitive ovarian cancer | 2016 | Marocco, F.; Vaira, M.; Milani, A.; Genta, S.; Maggiorotto, F.; Magistris, A.; Cinquegrana, A.; Robella, M.; De Simone, M.; Aglietta, M.; Ponzone, R.; Valabrega, G | |
| TOP2A as marker of response to pegylated lyposomal doxorubicin (PLD) in epithelial ovarian cancers | 2019 | Ghisoni, Eleonora; Maggiorotto, Furio; Borella, Fulvio; Mittica, Gloria; Genta, Sofia; Giannone, Gaia; Katsaros, Dionyssios; Sciarrillo, Alberto; Ferrero, Annamaria; Sarotto, Ivana; Erriquez, Jessica; Di Renzo, Maria Flavia; Aglietta, Massimo; Valabrega, Giorgio | |
| Veliparib: a new therapeutic option in ovarian cancer? | 2019 | Ghisoni, Eleonora; Giannone, Gaia; Tuninetti, Valentina; Genta, Sofia; Scotto, Giulia; Aglietta, Massimo; Sangiolo, Dario; Mittica, Gloria; Valabrega, Giorgio |